| Consensus guidelines for the management of plaque psoriasis S Hsu, KA Papp, MG Lebwohl, J Bagel, A Blauvelt, KC Duffin, J Crowley, ... Archives of dermatology 148 (1), 95-102, 2012 | 245 | 2012 |
| Why topical retinoids are mainstay of therapy for acne J Leyden, L Stein-Gold, J Weiss Dermatology and therapy 7, 293-304, 2017 | 164 | 2017 |
| Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses M Lebwohl, S Shumack, LS Gold, A Melgaard, T Larsson, SK Tyring JAMA dermatology 149 (6), 666-670, 2013 | 155 | 2013 |
| CUTIS Do Not Copy JQ Del Rosso, D Thiboutot, R Gallo, G Webster, E Tanghetti, L Eichenfield, ... Cutis 92, 234-240, 2013 | 148 | 2013 |
| Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee D Thiboutot, R Anderson, F Cook-Bolden, Z Draelos, RL Gallo, ... Journal of the American Academy of Dermatology 82 (6), 1501-1510, 2020 | 140 | 2020 |
| Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO‐ABLE study C Paul, L Stein Gold, F Cambazard, RE Kalb, D Lowson, B Bang, ... Journal of the European Academy of Dermatology and Venereology 31 (1), 119-126, 2017 | 132 | 2017 |
| A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized … A Blauvelt, K Papp, A Gottlieb, A Jarell, K Reich, C Maari, KB Gordon, ... British journal of dermatology 182 (6), 1348-1358, 2020 | 129 | 2020 |
| Phase 3 trials of tapinarof cream for plaque psoriasis MG Lebwohl, L Stein Gold, B Strober, KA Papp, AW Armstrong, J Bagel, ... New England Journal of Medicine 385 (24), 2219-2229, 2021 | 124 | 2021 |
| Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials A Hebert, D Thiboutot, LS Gold, M Cartwright, M Gerloni, E Fragasso, ... JAMA dermatology 156 (6), 621-630, 2020 | 121 | 2020 |
| Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor–modulating agent R Bissonnette, LS Gold, DS Rubenstein, AM Tallman, A Armstrong Journal of the American Academy of Dermatology 84 (4), 1059-1067, 2021 | 119 | 2021 |
| Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne J Tan, D Thiboutot, G Popp, M Gooderham, C Lynde, J Del Rosso, ... Journal of the American Academy of Dermatology 80 (6), 1691-1699, 2019 | 117 | 2019 |
| Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials LS Gold, L Kircik, J Fowler, JM Jackson, J Tan, Z Draelos, A Fleischer, ... Journal of drugs in dermatology: JDD 13 (11), 1380-1386, 2014 | 113 | 2014 |
| A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne LS Gold, J Tan, A Cruz-Santana, K Papp, Y Poulin, J Schlessinger, ... Cutis 84 (2), 110-116, 2009 | 108 | 2009 |
| Trial of roflumilast cream for chronic plaque psoriasis MG Lebwohl, KA Papp, L Stein Gold, MJ Gooderham, LH Kircik, ... New England Journal of Medicine 383 (3), 229-239, 2020 | 104 | 2020 |
| Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis AS Paller, LS Gold, J Soung, AM Tallman, DS Rubenstein, M Gooderham Journal of the American Academy of Dermatology 84 (3), 632-638, 2021 | 102 | 2021 |
| Consensus recommendations from the American acne & rosacea society on the management of rosacea, part 4: a status report on physical modalities and devices. E Tanghetti, JQ Del Rosso, D Thiboutot, R Gallo, G Webster, ... Cutis 93 (2), 71-76, 2014 | 90 | 2014 |
| Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea. JQ Del Rosso, D Thiboutot, R Gallo, G Webster, E Tanghetti, ... Cutis 93 (3), 134-138, 2014 | 89 | 2014 |
| CUTIS Do Not Copy JQ Del Rosso, D Thiboutot, R Gallo, G Webster, E Tanghetti, ... Cutis 93, 18-28, 2014 | 89 | 2014 |
| Once-daily oral sarecycline 1.5 mg/kg/day is effective for moderate to severe acne vulgaris: results from two identically designed, phase 3, randomized, double-blind clinical … A Moore, LJ Green, S Bruce, N Sadick, E Tschen, P Werschler, ... Journal of drugs in dermatology: JDD 17 (9), 987-996, 2018 | 87 | 2018 |
| Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents JQ Del Rosso, D Thiboutot, R Gallo, G Webster, E Tanghetti, L Eichenfield, ... Cutis 92 (6), 277-284, 2013 | 85 | 2013 |
